- Home
- STSS vs ATNF Comparison
STSS vs ATNF Comparison
Compare STSS & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STSS
- ATNF
- Stock Information
- Founded
- STSS 2017
- ATNF 2016
- Country
- STSS United States
- ATNF United States
- Employees
- STSS N/A
- ATNF N/A
- Industry
- STSS Medical/Dental Instruments
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- STSS Health Care
- ATNF Health Care
- Exchange
- STSS Nasdaq
- ATNF Nasdaq
- Market Cap
- STSS 5.5M
- ATNF 5.0M
- IPO Year
- STSS 2022
- ATNF N/A
- Fundamental
- Price
- STSS $5.73
- ATNF $0.89
- Analyst Decision
- STSS
- ATNF
- Analyst Count
- STSS 0
- ATNF 0
- Target Price
- STSS N/A
- ATNF N/A
- AVG Volume (30 Days)
- STSS 149.1K
- ATNF 70.9K
- Earning Date
- STSS 08-13-2025
- ATNF 08-11-2025
- Dividend Yield
- STSS N/A
- ATNF N/A
- EPS Growth
- STSS N/A
- ATNF N/A
- EPS
- STSS N/A
- ATNF N/A
- Revenue
- STSS N/A
- ATNF N/A
- Revenue This Year
- STSS N/A
- ATNF N/A
- Revenue Next Year
- STSS N/A
- ATNF N/A
- P/E Ratio
- STSS N/A
- ATNF N/A
- Revenue Growth
- STSS N/A
- ATNF N/A
- 52 Week Low
- STSS $3.36
- ATNF $0.66
- 52 Week High
- STSS $2,224.20
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- STSS 45.95
- ATNF 48.21
- Support Level
- STSS $5.51
- ATNF $0.70
- Resistance Level
- STSS $5.95
- ATNF $0.93
- Average True Range (ATR)
- STSS 0.32
- ATNF 0.09
- MACD
- STSS 0.20
- ATNF 0.01
- Stochastic Oscillator
- STSS 66.25
- ATNF 58.79
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.